THE PILL THAT MOVES THE NEEDLE Trademark

Trademark Overview

On Wednesday, October 13, 2021, a trademark application was filed for THE PILL THAT MOVES THE NEEDLE with the United States Patent and Trademark Office. The USPTO has given the THE PILL THAT MOVES THE NEEDLE trademark a serial number of 97072349. The federal status of this trademark filing is REGISTERED as of Tuesday, December 10, 2024. This trademark is owned by Vaxart, Inc.. The THE PILL THAT MOVES THE NEEDLE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development of vaccines; vaccine research and development, namely, vaccine formulation services; research and laboratory testing of the formulation of vaccines; scientific research in the nature of clinical trials and research in the field of vaccines; and providing reports for all of the foregoing
the pill that moves the needle

General Information

Serial Number97072349
Word MarkTHE PILL THAT MOVES THE NEEDLE
Filing DateWednesday, October 13, 2021
Status700 - REGISTERED
Status DateTuesday, December 10, 2024
Registration Number7599887
Registration DateTuesday, December 10, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 22, 2022

Trademark Statements

Goods and ServicesResearch and development of vaccines; vaccine research and development, namely, vaccine formulation services; research and laboratory testing of the formulation of vaccines; scientific research in the nature of clinical trials and research in the field of vaccines; and providing reports for all of the foregoing

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, November 3, 2021
Primary Code042
First Use Anywhere DateTuesday, August 31, 2021
First Use In Commerce DateTuesday, August 31, 2021

Trademark Owner History

Party NameVaxart, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameVaxart, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameVaxart, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Saturday, October 16, 2021NEW APPLICATION ENTERED
Wednesday, November 3, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 19, 2022ASSIGNED TO EXAMINER
Tuesday, July 26, 2022NON-FINAL ACTION WRITTEN
Tuesday, July 26, 2022NON-FINAL ACTION E-MAILED
Tuesday, July 26, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, October 14, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, October 14, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 14, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 18, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 2, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 22, 2022PUBLISHED FOR OPPOSITION
Tuesday, November 22, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 17, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, June 30, 2023SOU TEAS EXTENSION RECEIVED
Friday, June 30, 2023SOU EXTENSION 1 FILED
Friday, June 30, 2023SOU EXTENSION 1 GRANTED
Tuesday, July 4, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 5, 2024TEAS STATEMENT OF USE RECEIVED
Tuesday, January 23, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, January 5, 2024SOU TEAS EXTENSION RECEIVED
Friday, January 5, 2024SOU EXTENSION 2 FILED
Friday, January 5, 2024USE AMENDMENT FILED
Tuesday, January 23, 2024SOU EXTENSION 2 GRANTED
Wednesday, January 24, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 16, 2024STATEMENT OF USE PROCESSING COMPLETE
Monday, November 18, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, November 18, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, December 10, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, December 10, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

needle moves pill research vaccines vaccine formulation development field trials providing clinical reports